SCHEMBL17253285

SCHEMBL17253285

CCN(c1ccc(/N=C2/C=C(Nc3ccc(N(CC)C(C)C)cc3)C(=O)C=C2Nc2ccccc2C)cc1)C(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.35
▸ KMT2A Q03164 7/20 0.35
▸ APAF1 O14727 6/20 0.35
▸ HTT P42858 6/20 0.35
▸ MEN1 O00255 6/20 0.35
▸ SMN1; SMN2 Q16637 4/20 0.35
▸ HPGD P15428 4/20 0.35
▸ KDM4E B2RXH2 4/20 0.35
▸ MITF O75030 2/20 0.35
▸ HKDC1 Q2TB90 2/20 0.35
▸ THRB P10828 2/20 0.35
▸ NR4A1 P22736 1/20 0.35
▸ SMAD3 P84022 1/20 0.35
▸ ALDH1A1 P00352 11/20 0.35
▸ BLM P54132 4/20 0.35
▸ TDP1 Q9NUW8 4/20 0.35
▸ LMNA P02545 4/20 0.35
▸ NPC1 O15118 4/20 0.35
▸ RAB9A P51151 4/20 0.35
▸ NPSR1 Q6W5P4 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15020290 1.00 MAPT (0.35) MAPTKMT2AAPAF1HTTMEN1
SCHEMBL15020289 1.00 MAPT (0.35) MAPTKMT2AAPAF1HTTMEN1
SCHEMBL15019814 0.90 APAF1 (0.39) MAPTKMT2AAPAF1HTTMEN1
SCHEMBL15019813 0.90 APAF1 (0.39) MAPTKMT2AAPAF1HTTMEN1
SCHEMBL15039564 0.90 APAF1 (0.39) MAPTKMT2AAPAF1HTTMEN1
SCHEMBL17253269 0.90 ALDH1A1 (0.37) MAPTKMT2AAPAF1HTTMEN1
SCHEMBL15020129 0.90 ALDH1A1 (0.37) MAPTKMT2AAPAF1HTTMEN1
SCHEMBL15020128 0.90 ALDH1A1 (0.37) MAPTKMT2AAPAF1HTTMEN1
SCHEMBL15039548 0.88 MAPT (0.41) MAPTKMT2AAPAF1HTTMEN1
SCHEMBL15020117 0.85 ALDH1A1 (0.35) MAPTKMT2AAPAF1HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9554977-B2 Triaromatic azomethine direct dyes, dye composition comprising at least one such dye, method of implementation and use L'OREAL (FR) 2017-01-31 — — US disclosed
US-20150320660-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2015-11-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150320660-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE KRT18, MKI67, CDC73 MAPT 469/4885KMT2A 1474/4885APAF1 3032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback